Exciting CEO opportunity with the IBD Registry – could you be our first Chief Executive?

The IBD Registry is looking for an exceptional individual to help drive the next phase of its growth, as it expands to become a new legal entity, founded by the British Society of Gastroenterology (BSG), Crohn’s and Colitis UK and the Royal College of Physicians (RCP).

The Registry team have achieved significant success to date; the new Chief Executive Officer will build on these achievements, and lead the team through an exciting and crucial growth stage in the Registry’s development. The role involves:

  • Heading up the operational team currently based near the RCP in London;
  • Responsibility for the financial and executive direction of the Registry;
  • With the Medical Director and the Board, setting the strategic direction of the new enterprise.

This is a fantastic opportunity to help shape a major UK initiative making a difference to the lives of people with Inflammatory Bowel Disease. Further details and a copy of the job pack can be found below.

Please share widely with your networks.

CEO advertDownload
CEO application packDownload

Applications close on Sunday 18th February at 19:00, with interviews planned to start on Tuesday 27th February 2018.

Find out more about:

 

Latest News

For clinical teams: next submission is 10 July 2020

Important information for Registry-participating clinical teams: with the COVID-19 outbreak, to ease pressure on clinical teams we postponed the last (April) submission deadline.  The next submission deadline is 10 July 2020 for data to the end of June, including all...

read more

Update on the COVID-19 UK IBD Tool for patients

Over 32,000 people in the UK with IBD have self-assessed their risk since launch on the 1 April 2020.  Between them, they have identified the 175 hospitals (Trusts and Health Boards) that provide them with care, and the data has been shared back to their doctors which...

read more

Abbreviated clinician news for IBD Teams – March 2020

Given the special circumstances putting pressure on IBD teams and wider health services, we have created some in-depth articles below in an easy to read format:  Switchers: Changing originator biologic to biosimilar Changing originator biologic to biosimilar With many...

read more

Registry surpasses 60,000 patient records

Huge congratulations to IBD clinical teams across the country - we have surpassed the 60,000 patient record mark. At time of writing we hold 63,181 records. 62 IBD teams submitted for this last quarter, 24% more than the same period last year. Figure: number of...

read more
%d bloggers like this: